2017 Award Recipient: Michael N. Hall, Ph.D.
When?
Monday, May 1, 2017
6:00 pm
Where?
National Press Club
529 14th Street NW,
Washington, DC 20045
Professor of Biochemistry, Biozentrum of the University of Basel, Switzerland
The 2017 Selection Committee announced cell growth research pioneer Michael N. Hall will receive the 2017 Szent-Györgyi Prize for Progress in Cancer Research.
In 1991, Hall discovered one of the most important cancer cell targets in the modern era of oncology, which he named “Target of Rapamycin” or TOR. He discovered that TOR – a conserved protein kinase – controls cell growth and a wide range of metabolic processes that when dysregulated cause disorders such as cancers, cardiovascular disease, diabetes and obesity. TOR inhibitors are used today in treatments for kidney, breast, brain and pancreatic cancers, and numerous clinical trials are currently underway testing TOR inhibitors in the treatments of many types of cancer.
Featured Items
“In the era of precision medicine, doctors want to use genetics to select the most effective drugs for each individual patient. It’s time to move beyond individual cancer types – different colored ribbons. By way of precision medicine, we will find cures for all types of cancer. By supporting NFCR’s scientists in their invaluable research endeavors, you are helping pave the way to do exactly that: cure cancer. We have all been affected by cancer in some way or other, or know those who have been. Make a decision to support them. Make a decision to help NFCR pave the way to finding a cure. Together, performing for ALL CANCERS, ALL COLORS, and through ALL ARTS, we will make a difference.” - Robin Xiaoge Wang, Chair, Arts4TheCure
Robin Xiaoge Wang, Chair, Arts4TheCure“I know that through donating to an organization like NFCR, I will be helping to sustain the work to create a future cure for cancer. By doing so, I recognize that I would be supporting a truly revolutionary long-term cure for cancer that will be able to save lives and families all over the world.” Learn More >>>
Chelsea Hu – Teen Mobile Arts“After researching many organizations online, I came across National Foundation for Cancer Research (NFCR),” Susan explained. “I developed a positive rapport with Executive Director Brian Wachtel, who shared more in-depth information and insights about the mission, vision, goals, accomplishments, and projections of this noble organization. I was excited about the support and their open-mindedness to creative opportunities of supporting the NFCR.” Learn More >>>
Susan B Schabacker, Musician“It’s a great feeling to know that we can be a conduit and help in any little way. Many musicians have dedicated their time to raising the money. They have been so generous.” Learn More >>>
George Unverzagt, The Acoustic Wolves“I was very impressed by everything I heard. I found the presented research to be of really high quality and very innovative. This is very refreshing, and, in my opinion, sets AIM-HI and NFCR apart in a very good way.” -Isidore Rigoutsos, Ph.D., Director, Center for Computational Medicine, Thomas Jefferson University
Isidore Rigoutsos, Ph.D.
